Avience Biomedicals IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Jun 18 to Jun 22 2026
Price Band
₹196 - 208
Current GMP
₹395.2 (+90%)
Subscription
385.24 times
IPO Details
| IPO Date | 18 to 22 Jun, 2026 |
| Listing Date | Thu, Jun 25, 2026 |
| Face Value | ₹ 10 per share |
| Price Band | ₹196 to ₹208 |
| Issue Price | ₹208 per share |
| Lot Size | 600 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 14,53,800 shares (agg. up to ₹ 30 Cr) |
| Reserved for Market Maker | 82,200 shares (agg. up to ₹ 2 Cr) Asnani Stock Broker Pvt.Ltd. |
| Fresh Issue (Ex Market Maker) | 13,71,600 shares (agg. up to ₹ 29 Cr) |
| Net Offered to Public | 13,71,600 shares (agg. up to ₹ 29 Cr) |
| Share Holding Pre Issue | 40,31,256 shares |
| Share Holding Post Issue | 54,85,056 shares |
| / NSE Symbol | / AVIENCE |
| ISIN | INE0V9I01017 |
IPO Date
18 to 22 Jun, 2026
Listing Date
Thu, Jun 25, 2026
Face Value
₹ 10 per share
Price Band
₹196 to ₹208
Issue Price
₹208 per share
Lot Size
600 Shares
Sale Type
Fresh capital only
Issue Type
Bookbuilding IPO
Listing At
NSE SME
Total Issue Size
14,53,800 shares (agg. up to ₹ 30 Cr)
Reserved for Market Maker
82,200 shares (agg. up to ₹ 2 Cr) Asnani Stock Broker Pvt.Ltd.
Fresh Issue (Ex Market Maker)
13,71,600 shares (agg. up to ₹ 29 Cr)
Net Offered to Public
13,71,600 shares (agg. up to ₹ 29 Cr)
Share Holding Pre Issue
40,31,256 shares
Share Holding Post Issue
54,85,056 shares
/ NSE Symbol
/ AVIENCE
ISIN
INE0V9I01017
IPO Subscription Details
| Anchor | 1 |
| Market Maker | 1 |
| QIB (Ex Anchor) | 196.77 |
| NII*** | 597.23 |
| bNII (> ₹10L) | 670.18 |
| sNII (< ₹10L) | 451.32 |
| Individual Investors | 401.21 |
| Total ** | 385.24 |
Anchor
1
Market Maker
1
QIB (Ex Anchor)
196.77
NII***
597.23
bNII (> ₹10L)
670.18
sNII (< ₹10L)
451.32
Individual Investors
401.21
Total **
385.24
Day Wise Sub
| Day | QIB (Ex Anchor) | NII* | NII (> ₹10L) | NII (< ₹10L) | Individual Investors | Total |
|---|---|---|---|---|---|---|
| Jun 1 8 (Day 1) | 0.00 | 13.49 | 13.66 | 13.14 | 15.69 | 10.75 |
| Jun 1 9 (Day 2) | 0.03 | 66.36 | 66.08 | 66.91 | 58.97 | 43.79 |
| Jun 2 2 (Day 3) | 196.77 | 597.23 | 670.18 | 451.32 | 401.21 | 385.24 |
DayJun 1
8 (Day 1)
QIB (Ex Anchor)0.00
NII*13.49
NII (> ₹10L)13.66
NII (< ₹10L)13.14
Individual Investors15.69
Total10.75
DayJun 1
9 (Day 2)
QIB (Ex Anchor)0.03
NII*66.36
NII (> ₹10L)66.08
NII (< ₹10L)66.91
Individual Investors58.97
Total43.79
DayJun 2
2 (Day 3)
QIB (Ex Anchor)196.77
NII*597.23
NII (> ₹10L)670.18
NII (< ₹10L)451.32
Individual Investors401.21
Total385.24
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 25-06-2026 | 208.00 | 145(69.71%) | 353 |
| 24-06-2026 | 208.00 | 145(69.71%) | 353 |
| 23-06-2026 | 208.00 | 95(45.67%) | 303 |
| 22-06-2026 | 208.00 | 72(34.62%) | 280 |
| 21-06-2026 | 208.00 | 70(33.65%) | 278 |
| 20-06-2026 | 208.00 | 85(40.87%) | 293 |
| 19-06-2026 | 208.00 | 85(40.87%) | 293 |
| 18-06-2026 | 208.00 | 85(40.87%) | 293 |
| 17-06-2026 | 208.00 | 75(36.06%) | 283 |
| 16-06-2026 | 208.00 | 63(30.29%) | 271 |
| 15-06-2026 | 208.00 | 70(33.65%) | 278 |
| 14-06-2026 | 0(0.00%) | (0.00%) | |
| 13-06-2026 | 0(%) | (%) |
Date25-06-2026
Price208.00
GMP145(69.71%)
Estimate List Price353
Date24-06-2026
Price208.00
GMP145(69.71%)
Estimate List Price353
Date23-06-2026
Price208.00
GMP95(45.67%)
Estimate List Price303
Date22-06-2026
Price208.00
GMP72(34.62%)
Estimate List Price280
Date21-06-2026
Price208.00
GMP70(33.65%)
Estimate List Price278
Date20-06-2026
Price208.00
GMP85(40.87%)
Estimate List Price293
Date19-06-2026
Price208.00
GMP85(40.87%)
Estimate List Price293
Date18-06-2026
Price208.00
GMP85(40.87%)
Estimate List Price293
Date17-06-2026
Price208.00
GMP75(36.06%)
Estimate List Price283
Date16-06-2026
Price208.00
GMP63(30.29%)
Estimate List Price271
Date15-06-2026
Price208.00
GMP70(33.65%)
Estimate List Price278
Date14-06-2026
Price
GMP0(0.00%)
Estimate List Price(0.00%)
Date13-06-2026
Price
GMP0(%)
Estimate List Price(%)
IPO Important Dates
| IPO Open | Thu, Jun 18, 2026 |
| IPO Close | Mon, Jun 22, 2026 |
| Allotment | Tue, Jun 23, 2026 |
| Refund | Wed, Jun 24, 2026 |
| Credit of Shares | Wed, Jun 24, 2026 |
| Listing | Thu, Jun 25, 2026 |
IPO Open
Thu, Jun 18, 2026
IPO Close
Mon, Jun 22, 2026
Allotment
Tue, Jun 23, 2026
Refund
Wed, Jun 24, 2026
Credit of Shares
Wed, Jun 24, 2026
Listing
Thu, Jun 25, 2026
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (IND) (Min) | 2 | 1,200 | ₹2,49,600 |
| Individual investors (IND) (Max) | 2 | 1,200 | ₹2,49,600 |
| S-HNI (Min) | 3 | 1,800 | ₹3,74,400 |
| S-HNI (Max) | 8 | 4,800 | ₹9,98,400 |
| B-HNI (Min) | 9 | 5,400 | ₹11,23,200 |
ApplicationIndividual investors (IND) (Min)
Lots2
Shares1,200
Amount₹2,49,600
ApplicationIndividual investors (IND) (Max)
Lots2
Shares1,200
Amount₹2,49,600
ApplicationS-HNI (Min)
Lots3
Shares1,800
Amount₹3,74,400
ApplicationS-HNI (Max)
Lots8
Shares4,800
Amount₹9,98,400
ApplicationB-HNI (Min)
Lots9
Shares5,400
Amount₹11,23,200
Financial Information
| Period Ended | 31 Jan 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 66.07 | 56.52 | 34.65 |
| Total Income | 41.94 | 45.97 | 24.37 |
| Profit After Tax | 5.74 | 7.23 | 2.14 |
| EBITDA | 10.34 | 11.41 | 4.08 |
| NET Worth | 28.52 | 22.78 | 6.21 |
| Reserves and Surplus | 24.49 | 18.75 | 2.93 |
| Total Borrowing | 26.73 | 22.16 | 15.13 |
Period EndedAssets
31 Jan 202666.07
31 Mar 202556.52
31 Mar 202434.65
Period EndedTotal Income
31 Jan 202641.94
31 Mar 202545.97
31 Mar 202424.37
Period EndedProfit After Tax
31 Jan 20265.74
31 Mar 20257.23
31 Mar 20242.14
Period EndedEBITDA
31 Jan 202610.34
31 Mar 202511.41
31 Mar 20244.08
Period EndedNET Worth
31 Jan 202628.52
31 Mar 202522.78
31 Mar 20246.21
Period EndedReserves and Surplus
31 Jan 202624.49
31 Mar 202518.75
31 Mar 20242.93
Period EndedTotal Borrowing
31 Jan 202626.73
31 Mar 202522.16
31 Mar 202415.13
Key Performance Indicator
| ROE | 22.38% |
| ROCE | 16.99% |
| Debt/Equity | 0.94 |
| RoNW | 22.38% |
| PAT Margin | |
| EBITDA Margin | 24.70% |
| Price to Book Value | 2.94 |
ROE
22.38%
ROCE
16.99%
Debt/Equity
0.94
RoNW
22.38%
PAT Margin
EBITDA Margin
24.70%
Price to Book Value
2.94
IPO Reservation
| QIB Shares Offered | 6,83,400 |
| − Anchor Investor Shares Offered | 4,09,800 |
| − QIB (Ex. Anchor) Shares Offered | 2,73,600 |
| NII (HNI) Shares Offered | 2,07,000 |
| − bNII > ₹10L | 1,38,000 |
| − sNII < ₹10L | 69,000 |
| Retail Shares Offered | 4,81,200 |
| Market Maker Shares Offered | 82,200 |
| Total Shares Offered | 14,53,800 |
QIB Shares Offered
6,83,400
− Anchor Investor Shares Offered
4,09,800
− QIB (Ex. Anchor) Shares Offered
2,73,600
NII (HNI) Shares Offered
2,07,000
− bNII > ₹10L
1,38,000
− sNII < ₹10L
69,000
Retail Shares Offered
4,81,200
Market Maker Shares Offered
82,200
Total Shares Offered
14,53,800
Information about company
Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions, focusing on biotechnology, genomics, and the IVD industry.
Avience Biomedicals Limited has expanded its product range from IVD rapid test kits to a comprehensive line of medical devices, including serology products and biochemistry analyzers. This demonstrates a commitment to diverse healthcare needs, focusing exclusively on the B2B and B2G markets.
The company's products cater to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas.
In addition to manufacturing, the Company also act as distributors and traders of medical equipment.
The company's manufacturing unit is situated in Noida, Uttar Pradesh.
The company offers a comprehensive range of diagnostic solutions, including:
As of January 31, 2026, the company had 75 permanent employees and 33 contractual employees
Competitive Strength
Objectives of IPO
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
#: Issue Objects
1: Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
2: Funding the working capital requirements of the Company
3: General Corporate Purposes
: Total
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App